Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene
David Reich, Michael A Nalls, W H Linda Kao, Ermeg L Akylbekova, Arti Tandon, Nick Patterson, James Mullikin, Wen-Chi Hsueh, Ching-Yu Cheng, Josef Coresh, Eric Boerwinkle, Man Li, Alicja Waliszewska, Julie Neubauer, Rongling Li, Tennille S Leak, Lynette Ekunwe, Joe C Files, Cheryl L Hardy, Joseph M Zmuda, Herman A Taylor, Elad Ziv, Tamara B Harris, James G Wilson, David Reich, Michael A Nalls, W H Linda Kao, Ermeg L Akylbekova, Arti Tandon, Nick Patterson, James Mullikin, Wen-Chi Hsueh, Ching-Yu Cheng, Josef Coresh, Eric Boerwinkle, Man Li, Alicja Waliszewska, Julie Neubauer, Rongling Li, Tennille S Leak, Lynette Ekunwe, Joe C Files, Cheryl L Hardy, Joseph M Zmuda, Herman A Taylor, Elad Ziv, Tamara B Harris, James G Wilson
Abstract
Persistently low white blood cell count (WBC) and neutrophil count is a well-described phenomenon in persons of African ancestry, whose etiology remains unknown. We recently used admixture mapping to identify an approximately 1-megabase region on chromosome 1, where ancestry status (African or European) almost entirely accounted for the difference in WBC between African Americans and European Americans. To identify the specific genetic change responsible for this association, we analyzed genotype and phenotype data from 6,005 African Americans from the Jackson Heart Study (JHS), the Health, Aging and Body Composition (Health ABC) Study, and the Atherosclerosis Risk in Communities (ARIC) Study. We demonstrate that the causal variant must be at least 91% different in frequency between West Africans and European Americans. An excellent candidate is the Duffy Null polymorphism (SNP rs2814778 at chromosome 1q23.2), which is the only polymorphism in the region known to be so differentiated in frequency and is already known to protect against Plasmodium vivax malaria. We confirm that rs2814778 is predictive of WBC and neutrophil count in African Americans above beyond the previously described admixture association (P = 3.8 x 10(-5)), establishing a novel phenotype for this genetic variant.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- Forbes WH, Johnson RE, Consolazio F. Leukopenia in Negro workmen. Am J Med Sci. 1941;201:407–412.
- Broun GO, Jr, Herbig FK, Hamilton JR. Leukopenia in Negroes. N Engl J Med. 1966;275:1410–1413.
- van Assendelft OW. Reference values for the total and differential leukocyte count. Blood Cells. 1985;11:77–96.
- Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med. 2007;146:486–492.
- Haddy TB, Rana SR, Castro O. Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med. 1999;133:15–22.
- Nalls MA, Wilson JG, Patterson NJ, Tandon A, Zmuda JM, et al. Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. Am J Hum Genet. 2008;82:81–87.
- Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med. 1976;295:302–304.
- Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science. 1993;261:1182–1184.
- He W, Neil S, Kulkarni H, Wright E, Agan BK, et al. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe. 2008;4:52–62.
- Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449:851–861.
- Patterson N, Hattangadi N, Lane B, Lohmueller KE, Hafler DA, et al. Methods for high-density admixture mapping of disease genes. Am J Hum Genet. 2004;74:979–1000.
- de Bakker PI. 2008. .
- Ning Z, Cox AJ, Mullikin JC. SSAHA: a fast search method for large DNA databases. Genome Res. 2001;11:1725–1729.
- Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921.
- Kobyliansky E, Micle S, Goldschmidt-Nathan M, Arensburg B, Nathan H. Duffy, Kell and P blood group systems in some Jewish populations of Israel. Acta Anthropogenet. 1980;4:173–179.
- Mason BA, Lessin L, Schechter GP. Marrow granulocyte reserves in black Americans. Hydrocortisone-induced granulocytosis in the “benign” neutropenia of the black. Am J Med. 1979;67:201–205.
- Haddy TB, Rana SR. Leukocyte response to administration of corticosteroid in healthy black children with neutropenia. J Pediatr. 1994;124:739–741.
- Shoenfeld Y, Modan M, Berliner S, Yair V, Shaklai M, et al. The mechanism of benign hereditary neutropenia. Arch Intern Med. 1982;142:797–799.
- Phillips D, Rezvani K, Bain BJ. Exercise induced mobilisation of the marginated granulocyte pool in the investigation of ethnic neutropenia. J Clin Pathol. 2000;53:481–483.
- Tournamille C, Colin Y, Cartron JP, Le Van KC. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet. 1995;10:224–228.
- Peiper SC, Wang ZX, Neote K, Martin AW, Showell HJ, et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med. 1995;181:1311–1317.
- Szabo MC, Soo KS, Zlotnik A, Schall TJ. Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J Biol Chem. 1995;270:25348–25351.
- Gardner L, Patterson AM, Ashton BA, Stone MA, Middleton J. The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. Biochem Biophys Res Commun. 2004;321:306–312.
- Pruenster M, Rot A. Throwing light on DARC. Biochem Soc Trans. 2006;34:1005–1008.
- Bonecchi R, Borroni EM, Savino B, Buracchi C, Mantovani A, et al. Non-signaling chemokine receptors: mechanism of action and role in vivo. J Neuroimmunol. 2008;198:14–19.
- Lee JS, Frevert CW, Wurfel MM, Peiper SC, Wong VA, et al. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol. 2003;170:5244–5251.
- Luo H, Chaudhuri A, Zbrzezna V, He Y, Pogo AO. Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol Cell Biol. 2000;20:3097–3101.
- Edderkaoui B, Baylink DJ, Beamer WG, Wergedal JE, Porte R, et al. Identification of mouse Duffy antigen receptor for chemokines (Darc) as a BMD QTL gene. Genome Res. 2007;17:577–585.
- Mayr FB, Spiel AO, Leitner JM, Firbas C, Kliegel T, et al. Duffy antigen modifies the chemokine response in human endotoxemia. Crit Care Med. 2008;36:159–165.
- Hershman D, Weinberg M, Rosner Z, Alexis K, Tiersten A, et al. Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst. 2003;95:1545–1548.
- Hyman P, Westring DW. Leukocytosis in acute appendicitis. Observed racial difference. JAMA. 1974;229:1630–1631.
- Sadowitz PD, Oski FA. Differences in polymorphonuclear cell counts between healthy white and black infants: response to meningitis. Pediatrics. 1983;72:405–407.
- Shoenfeld Y, Ben Tal O, Berliner S, Pinkhas J. The outcome of bacterial infection in subjects with benign familial leukopenia (BFL). Biomed Pharmacother. 1985;39:23–26.
- Weingarten MA, Kahan E, Brauner A. Normal fluctuations of leucocyte counts and the response to infection in benign familial leucopenia. Acta Haematol. 1992;87:126–128.
- Taylor HA, Jr, Wilson JG, Jones DW, Sarpong DF, Srinivasan A, et al. Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn Dis. 2005;15:4–17.
- Visser M, Newman AB, Nevitt MC, Kritchevsky SB, Stamm EB, et al. Reexamining the sarcopenia hypothesis. Muscle mass versus muscle strength. Health, Aging, and Body Composition Study Research Group. Ann N Y Acad Sci. 2000;904:456–461.
- The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129:687–702.
- Fan JB, Oliphant A, Shen R, Kermani BG, Garcia F, et al. Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol. 2003;68:69–78.
- Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, et al. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am J Hum Genet. 2007;80:716–726.
- Lee LG, Connell CR, Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 1993;21:3761–3766.
- Reich D, Patterson N, De Jager PL, McDonald GJ, Waliszewska A, et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet. 2005;37:1113–1118.
- Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 2006
- Tang K, Fu DJ, Julien D, Braun A, Cantor CR, et al. Chip-based genotyping by mass spectrometry. Proc Natl Acad Sci U S A. 1999;96:10016–10020.
- Lettre G, Lange C, Hirschhorn JN. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol. 2007;31:358–362.
- Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, et al. Mapping and sequencing of structural variation from eight human genomes. Nature. 2008;453:56–64.
- Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. The sequence of the human genome. Science. 2001;291:1304–1351.
- Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, et al. The diploid genome sequence of an individual human. PLoS Biol. 2007;5:e254.
- Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 2001;409:928–933.
- Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, et al. A haplotype map of the human genome. Nature. 2005;437:1299–1320.
Source: PubMed